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Abstract
Animal African trypanosomiasis (AAT) is a severe, wasting disease of domestic livestock
and diverse wildlife species. The disease in cattle kills millions of animals each year and
inflicts a major economic cost on agriculture in sub-Saharan Africa. Cattle AAT is caused
predominantly by the protozoan parasites Trypanosoma congolense and T. vivax, but labo-
ratory research on the pathogenic stages of these organisms is severely inhibited by difficul-
ties in making even minor genetic modifications. As a result, many of the important basic
questions about the biology of these parasites cannot be addressed. Here we demonstrate
that an in vitro culture of the T. congolense genomic reference strain can be modified directly
in the bloodstream form reliably and at high efficiency. We describe a parental single marker
line that expresses T. congolense-optimized T7 RNA polymerase and Tet repressor and
show that minichromosome loci can be used as sites for stable, regulatable transgene
expression with low background in non-induced cells. Using these tools, we describe organ-
ism-specific constructs for inducible RNA-interference (RNAi) and demonstrate knockdown
of multiple essential and non-essential genes. We also show that a minichromosomal site
can be exploited to create a stable bloodstream-form line that robustly provides >40,000
independent stable clones per transfection–enabling the production of high-complexity
libraries of genome-scale. Finally, we show that modified forms of T. congolense are still
infectious, create stable high-bioluminescence lines that can be used in models of AAT, and
follow the course of infections in mice by in vivo imaging. These experiments establish a
base set of tools to change T. congolense from a technically challenging organism to a rou-
tine model for functional genetics and allow us to begin to address some of the fundamental
questions about the biology of this important parasite.
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Author summary
The parasites Trypanosoma congolense and T. vivax are the most significant causative
agents of Animal African trypanosomiasis (AAT). AAT kills an estimated 3 million cattle
each year and represents a huge financial burden on food production in sub-Saharan
Africa. A critical tool for understanding pathogen biology is the ability to make genetic
modifications, especially creating specific mutants of target genes that can be used to
investigate the locations of gene products, the effects of changes in expression, or conse-
quence of complete gene removal. However, work on AAT is severely limited by difficul-
ties in making even small genetic modifications and lack of tools for many functional
genetics applications. Here, we design, test and validate a set of tools for T. congolense that
brings for the first time: routine high-efficiency gene tagging and knockout, regulatable
transgene expression from silent loci, a species-specific system for inducible gene knock-
down, bioluminescent lines for in vivo disease models, and a means to generate highly
complex libraries of mutants that will enable genome-scale work. These data and the tools
around them will greatly aid research into AAT and T. congolense biology.
Introduction
Animal African trypanosomiasis (AAT) is a parasitic disease associated with anaemia, loss of
condition and death in sub-Saharan livestock. The impact of the disease on cattle farming is
particularly severe. Each year, AAT causes ~3 million cattle deaths, with economic losses in
cattle production alone estimated to be US$ 1–1.2 billion [1]. The disease in cattle is caused by
trypanosomes of the species Trypanosoma brucei (sub-species of which also cause human dis-
ease), T. vivax, and T. congolense. Of these species, T. congolense may cause the majority of dis-
ease in sub-Saharan cattle [2,3], as well as making up a substantial proportion of infections [4].
In spite of the importance of T. congolense and T. vivax for AAT, the vast majority of labo-
ratory research in African trypanosomes uses T. brucei, which is responsible for only a minor
proportion of infections. However, there are known to be significant differences in the biology
of these species, including in genomic content [5,6], antigenic variation [6–8], developmental
progression [9], and disease symptoms and tropism [10,11], in addition to the differences in
host specificity. There are also substantial differences in the differential regulation of genes
involved in specific biological processes during infection [12] and between metabolomes (Ste-
ketee et al., in preparation). Such differences create a pressing need for species-specific models
of AAT that can be used and modified in axenic culture and also transmitted through animals.
The focus of molecular research on T. brucei was historically driven by its association with
human disease, but recent bias has been heavily influenced by the paucity of means for per-
forming functional genetics in T. congolense. This is true for all lifecycle stages of T. congolense,
but is particularly acute for bloodstream-form cells, where even generation of stable transfor-
mants has been difficult–necessitating laborious strategies for genetic modification involving
multiple rounds of transfection and selection in procyclic cells followed by in vitro differentia-
tion first to epimastigotes, then to metacyclic cells and finally to bloodstream forms (some-
times requiring passage through animals; [13,14]). Where transfections have been performed,
they have been through application of plasmids designed and tested in T. brucei with little/no
modification. Moreover, there has been no establishment of silent loci suitable for integration
of inducible constructs, so although tetracycline-regulated gene expression has been demon-
strated in T. congolense [14], the level of regulation was very poor (~4-fold), precluding their
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use for applications such as expression of toxic gene products. Finally, work in T. brucei has
been fundamentally changed by the development of methods that enable the generation of
many thousands of transfectants from a single transfection [15], enabling the production of
high-complexity libraries, such as in the RIT-Seq approach for high-throughput testing of
RNA-interference mutants [16]. The lack of such methods in T. congolense severely restricts
our ability to probe the mechanisms of pathogenicity, lifecycle control and resistance to drugs,
amongst other critical questions.
Limitations in functional genetics tools for T. congolense not only restrict experimental
work to species that may not be good models for AAT infections, but prevent the addressing
of fundamental questions about the biology of these important species–including decoding the
genetic basis for the differences seen in their pathology, virulence and resistance to drugs. In
addition, since T. congolense is the only African trypanosome for which the whole lifecycle can
be recapitulated in vitro by means of chemical cues alone [14], this organism has unique
advantages as a model for studying differentiation across the African trypanosome clade.
Here, taking as a start point a stable axenic bloodstream culture of the genome reference strain
of T. congolense (IL3000), we have designed and implemented tools that allow direct, reliable
transgenesis of multiple types in the pathogenic stage of this species. We demonstrate efficient
modification of endogenous loci and gene knockout without the need for heterologous DNA
modifiers, such as recombinases, restriction endonucleases or Cas9. We describe the design
and use of a T. congolense-optimized construct to allow for inducible T7RNAP-driven expres-
sion and investigation of loci on the silent minichromosomes as sites for regulatable transgene
expression. We also build and test new T. congolense-specific constructs for RNA-interference
(RNAi) and describe a freeze/thaw-stable cell line enabling transfection efficiencies compatible
with the production of genome-scale high-complexity libraries. Finally, we produce a stable,
luminescent line that can be used in models of AAT in mice to increase efficiency of vaccinol-
ogy and drug development studies.
Results
Routine high-efficiency transfection in bloodstream-form T. congolense
Although transfection of procyclic (insect midgut) forms of T. congolense is generally routine–
albeit at low efficiency (~10 independent transfectants from a single transfection of ~108 pro-
cyclic cells; [17])–transfection of cultures of bloodstream-form T. congolense has been seen as
challenging, with the majority of transfections giving no stable transfectants at all [14]. How-
ever, very few loci have been targeted to date, and published transfection attempts in blood-
stream forms have used heterologous sequence from the T. brucei tubulin locus to direct
integration (~400 bp homology at each end with ~10% mismatch to T. congolense), the impact
of which on efficacy is unclear.
To test the efficiency of routine transfection directed by homologous targeting sequences in
bloodstream-form T. congolense, we took the stable axenic bloodstream culture of the IL3000
strain of T. congolense originally derived by Coustou et al. ([14]; kindly provided by Michael
Barrett, University of Glasgow) and targeted modifications to 9 different endogenous loci,
either as modifications to the 5’- or 3’-end of the CDS, or as complete knockout of a gene.
Unlike previous descriptions using heterologous sequence, 10 constructs with homologous
sequence, covering 4 different plasmid architectures (see Materials and Methods), could be
transfected at efficiencies more than sufficient for routine modification (100–4000 indepen-
dent clones per transfection; Fig 1A). These efficiencies are at or slightly above those we rou-
tinely achieve targeting endogenous loci in T. brucei Lister 427 cells (typically ~1000
independent clones). The same preparations of DNA gave very similar numbers of clones
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when transformed into procyclic-form IL3000 cells (Fig 1A). Moreover, in all clones tested
(n = 2–8, depending on transfection), correct integration of DNA could be confirmed by
detection of tagged protein or PCR, and sub-cellular localisations were in line with predictions
based on putative function (see Fig 1B for examples). These data demonstrate that there is no
intrinsic barrier to transgenesis in bloodstream-form T. congolense IL3000 and that specific
loci can be selectively targeted with good efficiency.
A ‘single-marker’ T. congolense line for regulated ectopic expression
Although regulatable systems based on IPTG [18], vanillic acid [19] and cumate [20] have
been used in T. brucei, the tetracycline-based system is to date the best characterised and best
regulated [21]. A bloodstream-form T. congolense cell line expressing bacterial tetracycline-
repressor protein (TetR) and T7 bacteriophage RNA polymerase (T7RNAP) has been gener-
ated previously by in vitro differentiation of a procyclic IL3000 cells [14], but this line: i) uses 2
selection markers that would otherwise be available for further modification, ii) depends on
heterologous sequences for processing of transgenes, and iii) does not include the codon-opti-
mization used in the T. brucei SmOx lines [22] that has been shown to increase expression in
this organism [23]. As a basis for regulated ectopic expression in T. congolense, we designed
and built a single-marker construct (pTcoSM) that modifies the T. congolense tubulin locus by
full replacement of a TUBB CDS with codon-optimized T7RNAP and TetR. Similarly to T. bru-
cei pSmOx [22], pTcoSM integrates into the T. congolense genome without bacterial DNA to
Fig 1. High-efficiency modification of endogenous loci in bloodstream-form T. congolense. A) Numbers of independent stable clones produced from
electroporation of ~2.5×107 cells with 10–15 μg linearised DNA targeting CDS encoding fluorescent proteins (sfG, superfolder GFP; Y, eYFP; mSt,
mStrawberry; mSc, mScarlet-I) to endogenous loci in T. congolense. Modifications are either N-terminal tags (RPA2, CITFA2, Nopp140, Vex1), C-terminal
tags (ESPs), or full replacement of a gene (Δtubb::GFP). Selection of integrants with genes conferring resistance to hygromycin (HYG) or G418 (NEO) give
100–5000 independent clones from a single transfection in both bloodstream-form (BSF) and procyclic-form (PCF) cells. Bars: 90% confidence intervals
for estimates of clone numbers resulting from individual transfections (reflecting the total number of wells counted). B) Examples of localisation of
expressed tagged proteins to expected cellular compartments in bloodstream-form T. congolense. T. congolense ESP10 homologue localises to the flagellar
pocket region, visualised with fluorophore-conjugated tomato lectin (TL), while T. congolense Nopp140 localises to the nucleolus. Representative
interphase cells are shown. See S1 Fig for larger fields of cells.
https://doi.org/10.1371/journal.ppat.1009224.g001
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avoid potential mis-integration when using additional constructs containing common plasmid
sequence, but in pTcoSM all introduced CDS are flanked by intergenic sequences associated
with highly-expressed T. congolense loci (tubulin, PFR1 and PFR2; Fig 2A).
Transfection of pTcoSM into bloodstream-form IL3000 cells generated the T. congolense
single marker line, TcoSM. Transcriptome analysis showed levels of T7RNAP and TetR
mRNA in TcoSM are higher than in T. brucei ‘single-marker bloodstream’ cells [21], which
have been very widely used in this organism, and similar to T. brucei lines carrying the pSmOx
modification (Fig 2B and 2C), demonstrating both pol II read-through and processing of
transgenes by the homologous intergenic sequences as expected. The discontinuation of com-
mercial antibodies against T7RNAP precluded the direct testing of levels for this protein, but
levels of TetR were also substantially above those in SMB cells (Fig 2D) which, together with
the high mRNA levels, suggested levels of protein suitable for regulated expression.
Fig 2. Production of a ‘single marker’ bloodstream-form T. congolense line (TcoSM) for inducible expression of transgenes. A) Schematic
representation of genetic modification in TcoSM cells. PAC confers resistance to puromycin. TcoPFR1 and TcoPFR2 are the intergenic regions between
copies of the native T. congolense IL3000 PFR1 and PFR2 arrays, respectively. B) Quantitation of mRNA levels for transgenes in TcoSM against common
modifications of T. brucei (SMB, Wirtz et al. ‘single-marker bloodstream’ cells [21]; AnTat-SMOx, pleomorphic EATRO1125 bloodstream cells transformed
with the Poon et al. pSmOx plasmid [22]; see Figs 8 and 10 for modifications producing TcoSM-LUC2 and TcoTTS cells). Read density is normalised to total
reads resulting from TUBA. C) Read density across the modified regions in SMB, AnTat-SMOx and TcoSM cells. Peaks in intergenic regions in
untransformed parental lines shows reads mapping to UTRs shared between integrated DNA and endogenous loci. D) Levels of transgenic TetR produced in
modified cells assessed by immunoblotting of whole cell lysates with an anti-TetR monoclonal antibody. A section (encompassing the VSG region) of the
same membrane stained with Ponceau S is shown as a control for loading. ‘wt’ indicates unmodified parental cells. The TetR protein in SMB cells lacks the
N-terminal NLS used in AnTat-SMOx and TcoSM, so has a lower molecular mass. Data from one of two biological replicates are shown. See S2 Fig for full
view of immunoblot membrane.
https://doi.org/10.1371/journal.ppat.1009224.g002
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Inducible transgene expression from stable T. congolense
minichromosomal loci
Essential for the development of well-regulated systems for inducible expression in T. brucei
has been the identification of loci that are normally transcriptionally silent, but can support
high-level transcription on induction. Lack of such identified loci is likely the major cause of
the poor regulation (only 2.8- to 4.5-fold) seen in previous attempts at inducible transgene
expression in T. congolense, as tetracycline-responsive elements were integrated into the active
tubulin locus resulting in substantial expression in the absence of induction [14].
The most common integration target in T. brucei is a spacer region found between arrayed
copies of the 18S/28S ribosomal RNA polycistron. Targeting this sequence in the opposite ori-
entation to rRNA transcription can provide >1000-fold transgene regulation [21,24], although
regulation appears to be highly dependent on the precise spacer at which integration occurs
[24–26]. Unlike in T. brucei, the 18S/28S rRNA polycistrons in T. congolense do not appear to
be arrayed [5], so there is no site homologous to the T. brucei rRNA spacer. Integration has
been successfully directed to a non-homologous sequence upstream of the T. congolense rRNA
promoter [27,28], but it is unclear if this site offers the same level of transcriptional regulation
as the T. brucei rRNA spacer. As an alternative to sites on the housekeeping chromosomes, loci
on the transcriptionally silent minichromosomes have been shown to provide sites for consis-
tent, well-regulated expression in T. brucei [26,29]. As minichromosomes are even more abun-
dant in T. congolense than in T. brucei [5] and transcriptomic data suggest them to be silent
[12], we reasoned they might make good integration sites for regulated expression.
To test the utility of T. congolense minichromosomes as sites for regulated expression, we
targeted a GFP and hygromycin resistance marker polycistron transcribed by a single tetracy-
cline-responsive T7 promoter to 3 sequences present on minichromosomal contigs in the
recent long-read assembly of the IL3000 genome [5]: i) the 369 bp repeat found abundantly on
minichromosomes [30,31], ii) loci encoding an expanded family of putative DEAH-box RNA
helicases (DBRH) related to Tb927.6.740 but present on minichromosomes in T. congolense
(e.g. TcIL3000.A.H_000093500), and iii) a silent telomeric VSG gene (TcIL3000.A.
H_000093600). 369 bp repeat and silent VSG were targeted with an efficiency indistinguishable
from modifications made at pol II transcribed loci (Figs 1A and 3B). These efficiencies are con-
sistent with integration into the T. congolense genome being independent of target copy num-
ber, as is also seen in T. brucei [32], as targets present in the long-read assemblies at 1, 30 and
13 000 copies per haploid genome direct integration with the same efficiency (Fig 3B). In con-
trast, transfection targeting DBRH produced ~20-fold fewer clones. This was independent of
whether transgene transcription ran in the same or opposite orientation to the DBRH coding
direction, showing that the effect was not a product of a specific DNA preparation, but likely
an intrinsic property of either the targeting sequence (e.g. due to heterogeneity in sequence
across the family) or inability of some of these loci to support transgene expression.
All successfully selected transfectants supported T7-driven expression at levels greatly
above those from pol II read-through at the tubulin locus (Figs 3C and 4A). Mean protein lev-
els were ~20-times higher when T7RNAP transcribed compared to pol II, which is at least as
good as those from SMB or 90-13 T. brucei cells (~12 and 15-times, respectively; [21]), con-
firming that there is good production of T7RNAP in TcoSM cells. Removal of tetracycline
reduced mean fluorescence of transfectants to background levels (>500-fold regulation at the
protein level) for all except cells containing transgenes integrated into DBRH in the coding ori-
entation, where there was substantial fluorescence in the absence of tetracycline (Figs 4A and
S3). Interestingly, this does not appear to be due to direct basal transcription of GFP by
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Fig 3. Integration of inducible constructs at T. congolense minichromosomal loci. A) Schematic representation of integrated construct
and loci targeted. VSG, silent minichromosomal VSG TcIL3000.A.H_000093600; DBRH, gene encoding putative ATP-dependent DEAH-
box RNA helicase (e.g. TcIL3000.A.H_000093500); 369bp repeat, minichromosome-specific satellite repeat [5,31]. Constructs targeting
DBRH are identical other than integrating with inducible transcription running in the forward (F) or reverse (R) direction relative to
DBRH CDS. B) Transfection efficiency when directing integration to minichromosomal or TUBB loci. ‘Copy number’ refers to number in
the TriTrypDB T. congolense IL3000_2019 assemblies (v46) based on the work of [5]. Bars: 90% confidence intervals for estimates of clone
numbers resulting from individual transfections. C) Expression of GFP (green) in cells in the presence of tetracycline. Counter-staining of
cells with 40,6-diamidino-2-phenylindole (DAPI; magenta) is also shown. All lines were captured and processed equally, except that GFP
signal from Δtubb::GFP has been increased 6-fold for visualisation. Representative images from one clone for each modification are
shown.
https://doi.org/10.1371/journal.ppat.1009224.g003
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endogenous pol II, but to high-level GFP production in a sub-population of cells–presumably
due to transient displacement of TetR (S3 Fig).
Induced GFP levels for 14 of 15 lines were essentially unchanged by growth for 21 days in
the absence of transgene selection (Fig 4B), showing that most T. congolense minichromosomal
loci have sufficient stability with respect to mitosis to also be good sites for transgenetic modifi-
cations where it may not be possible to constantly maintain selective drug (e.g. in vivo).
Direct inducible RNA interference in T. congolense bloodstream forms
Due to difficulties in performing genetic modifications, no previous work has performed
RNAi by direct modification of bloodstream-form T. congolense–instead making modifica-
tions (at actively transcribed loci) in procyclic cells and then differentiating to bloodstream
forms, either with [13] or without [14] passage through animals. To take advantage of the abil-
ity to stably modify minichromosomal loci in bloodstream-form T. congolense, we designed 3
constructs for inducible RNAi that integrate at the silent minichromosomal VSG, TcIL3000.A.
H_000093600. These constructs contain a tetracycline-responsive RNAi cassette slightly modi-
fied from p2T7Ti [33] that is widely used in T. brucei, a constitutively-expressed selection cas-
sette derived from those providing the greatest transfection efficiency for endogenous-locus
modification (Fig 1A), and targeting sequence to integrate at the silent VSG without bacterial
Fig 4. Regulated expression from T. congolense minichromosomal loci. Constructs and target sequences are as in Fig 3. A) Quantification of GFP regulation. Mean
fluorescence in 0 (non-induced) or 1 μg ml-1 (induced) tetracycline was calculated by flow cytometry and is shown as levels above mean background (untagged TcoSM
cells). For comparison, range of triplicate measurements from 2 independent clones of Δtubb::GFP are also shown. Clone number is shown below x-axis. ‘pop’
indicates data from uncloned populations. Distributions of fluorescence for each cell line are shown in S3 Fig. B) Change in mean induced GFP levels following
maintenance of cells for 21 days (~50 generations) without selection. Individual points represent same clones/populations as shown in Fig 3D and are from a single
experimental replicate.
https://doi.org/10.1371/journal.ppat.1009224.g004
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DNA (Fig 5A). Three different arrangements of promoter and terminator around the selection
cassette were tested in the plasmids: p2T7-TcoV (NEO-expression driven by the T. congolense
rRNA promoter), p3T7-TcoV (T7-driven NEO expression), and p3T7-TcoVTT (T7-driven
expression terminated at end of cassette).
To test the efficiency of knockdown without the confounding influence of gene essentiality,
we directed RNAi against a heterologous gene (GFP) integrated into the tubulin locus by
inducible expression of ~600 bp GFP double-stranded RNA. Herein, this RNAi is indicated
δgfp by analogy to nomenclature used for gene knock-outs. All three T. congolense-specific
RNAi plasmids reduced the abundance of GFP on induction (Figs 5B and S3), although
knockdown was weaker in lines with pol I-driven selection than those with three T7 promoters
(presumably as a result of transcriptional interference). There was no evidence at the protein
level for leakiness of RNAi in the absence of tetracycline, but greatest knockdown was only to
30–40% of non-induced levels for the best performing construct (p3T7-TcoV). Similar levels
of knockdown were seen when targeting an endogenous gene encoding flagellar pocket pro-
tein ESP14 [34]; although in T. brucei, RNAi against ESP14 reduces proteins levels to an esti-
mated<10% of parental, knockdown of the T. congolense orthologue (TcIL3000_7_180) is
only to ~30% (Fig 5C and 5D). This effect is manifest at the RNA level, as RNAi targetted
against a further 5 endogenous genes (PPDK, TcIL3000.A.H_000922100; CHC, TcIL3000.A.
H_000768200; FBPase, TcIL3000.A.H_000671500; FH1, TcIL3000.A.H_000909500; PEPCK,
TcIL3000.A.H_000300300) by dsRNAs of 493–707 bp consistently reduced mRNA levels, but
only to 30–60% of parental or non-induced levels (Fig 5E and 5F).
Given that T7-driven transcription in TcoSM cells from minichromosomal loci is at least as
strong (in comparison to pol II transcription) as seen in T. brucei bloodstream forms [21], the
lower penetrance of RNAi in IL3000 T. congolense does not appear to be a feature of integra-
tion site. Indeed, levels of knockdown with p3T7-TcoV are considerably stronger than for
inducible constructs integrated at the tubulin locus (without the apparent reduction of levels
in non-induced cells), and as strong as for constitutively expressed hairpins introduced into
the genome [13]. Instead, it is likely that there is an intrinsically lower effect size resulting from
expression of double-strand RNA in T. congolense, at least for the genome reference strain.
Inducible knockdown of essential genes in T. congolense bloodstream forms
To test if levels of RNAi knockdown in T. congolense could produce defects expected due to
loss of essential proteins, we used p3T7-TcoV to knockdown genes encoding α-tubulin (e.g.
TcIL3000.A.H_000560300; δtuba) and clathrin heavy chain (TcIL3000.A.H_000768200; δchc).
Knockdown of these genes produce distinctive ‘FAT’ and ‘BigEye’ phenotypes when targeted
in T. brucei [35,36]. Consistent with RNAi against non-essential genes, RNAi reduced CHC
mRNA levels to ~30% of parental (Fig 5E). Both δtuba and δchc produced the expected mor-
phological change in ~50% of cells in independent clonal populations by 48 h post-induction
(56% and 54% for δtuba and δchc, respectively; Fig 6A and 6B), similar to proportions of cells
with morphological defects seen previously in inducible knockdown of α-tubulin in procyclic-
form T. congolense [28]. Again, these data are compatible with an intrinsically lower pene-
trance of RNAi in IL3000 compared to T. brucei strains. They also suggest that there may be
some attenuation of RNAi effect at later time points–as seen in a reduction of δchc cells with
an detectable morphological defect at 72 h versus 48 h (Fig 6B; mean 35% and 54%, respec-
tively) and a slight increase in mRNA levels for all genes followed over 72 h induction (Fig 5F).
Induction of RNAi against either TUBA or CHC caused a growth defect in all clones ana-
lysed from 24 h post-induction (Fig 6C). However, even though defects were still apparent at
later time points, in neither case did populations stop dividing completely–doubling every
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20.0 ± 1.8 h and 19.3 ± 2.0 h after 24 h induction for δtuba and δchc, respectively, compared to
10.3 ± 0.3 h for non-induced cells. Cells not producing a detectable morphological defect early
in induction are not due to a substantial proportion of cells refractory to RNAi in the non-
Fig 5. Inducible RNA-interference from a silent minichromosomal locus in bloodstream-form T. congolense. Numbers in parentheses following knockdown
name refer to the total length of the gene fragment inserted between promoters in the RNAi construct. A) Schematic representation of RNAi construct architectures
and integration. B) Quantification of knockdown of GFP expressed from the tubulin locus by RNAi targeting GFP (δgfp). Numbers on the x-axis represent
independent clones. C) Localisation of the T. congolense orthologue of ESP14 (TcIL3000_7_180) by endogenous-locus tagging. Counter-staining of cells with DAPI
(magenta) is also shown. D) Knockdown of endogenous locus-tagged ESP14 in bloodstream-form T. brucei and two independent clones of T. congolense. E)
Quantification of target transcript levels following RNAi targeting pyruvate phosphate dikinase (TcIL3000.A.H_000922100, δppdk) or clathrin heavy chain (δchc)
genes. Mean and SEM from 3 (δppdk) or 4 (δchc) biological replicates are shown along with individual measurements (dots). F) Time courses for target transcript
levels following RNAi targeting 4 genes with putative metabolic roles. Bars: SEM from 3 biological replicates.
https://doi.org/10.1371/journal.ppat.1009224.g005
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induced population, as they produce progeny that can be affected by knockdown. Instead, there
appears to be a relatively stable proportion of the population where levels fall below a threshold
necessary for apparent defect, at least in the short-term following induction. Importantly, this
proportion was unchanged by freeze-thawing of clones, meaning that RNAi lines can be stored
and re-analysed in future experiments (S4 Fig). However, there was some attenuation of RNAi
defects after growth in culture without induction for 8 weeks (>120 generations; S4 Fig),
Fig 6. RNAi targeting essential genes in T. congolense causes growth defects and morphological changes similar to
those seen in T. brucei. A) Phenotypic changes seen following knockdown of α-tubulin (δtuba) or clathrin heavy
chain (δchc) in T. congolense. Images from 2 technical replicates of induction of a single clone (Clone 1) are shown. B)
Quantification of gross morphological changes. Representative data from 1 of 2 biological repeats are shown. Numbers
below bars are time post-induction (h); numbers above are cells analysed; P, parental (no RNAi construct). C) Growth
of cells containing RNAi constructs in 0 (non-induced) or 1 μg ml-1 (induced) tetracycline.
https://doi.org/10.1371/journal.ppat.1009224.g006
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suggesting that there is some long-term pressure imposed by the presence of the RNAi con-
struct–even without induction.
Inducible double-strand break creation in T. congolense minichromosomes
A key technical development in the evolution of T. brucei genetic modification was the demon-
stration that double-strand breaks at specific loci could hugely increase the efficiency and spec-
ificity of transgene integration [15]. This is a critical component of high-complexity library
approaches such as genome-scale RNA-interference target sequencing (RIT-Seq; [16]). The
technology as currently applied in T. brucei involves introducing an I-SceI meganuclease rec-
ognition sequence at the target locus followed by transient expression of I-SceI to induce cut-
ting. To implement a similar approach at T. congolense minichromosomes, we designed and
built constructs to introduce an inducible, self-excising gene encoding I-SceI (with a monopar-
tite nuclear localisation sequence from SV40 Large T-antigen) at the silent minichromosomal
VSG (Fig 7A).
Fig 7. Production of inducible, self-excising locus on T. congolense minichromosome. A) Schematic representation
of construct architectures and integration. B) Experimental set-up for estimation of locus loss. Tet, tetracycline; Hyg,
hygromycin; P(TbrRNA), T. brucei rRNA gene promoter. C) Number of positive wells on input plate and replicas in
the absence (-Hyg) or presence (+Hyg) of hygromycin. D) Inferred proportion of hygromycin-sensitive cells following
induction. Three independent clones are shown for pTcoScetiT7 (1–3). Bars: 90% confidence intervals for estimates
from individual biological replicates.
https://doi.org/10.1371/journal.ppat.1009224.g007
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In T. brucei, the published approach targeting a rDNA spacer has the disadvantage that
leakiness in I-SceI expression means that cells containing the I-SceI construct (known as Sce�
cells) are unstable on freeze-thaw and also during medium-term culture [37]. Although our
data suggest levels of transgene expression from the targeted locus are very low in the absence
of induction (Fig 4), it is not known what level of protein is necessary to produce cutting in a
significant proportion of cells. To accommodate differences in I-SceI threshold, constructs
were designed with the gene under the control of 2 alternative promoters (both controlled by
two TetO elements): a T7 promoter (pTcoScetiT7) expected to produce very strong expression,
and a heterologous promoter for the rRNA genes from T. brucei (pTcoSceTbrRNA). The latter is
highly dissimilar to the endogenous rRNA promoter and our data suggest it results in very low
transgene expression when used in T. congolense, but is known to be well regulated in T. brucei
[25].
Cutting of I-SceI in cells transfected with either pTcoScetiT7 or pTcoSceTbrRNA would cause
loss of telomere-proximal SceI and HYG (Fig 7A). To test for the efficiency of double-strand
break induction, we grew cells for 48 h in the presence or absence of tetracycline, plated with-
out selection and then applied drug selection to test for loss of HYG (Fig 7B). Cells containing
I-SceI controlled by heterologous TbrRNA promoter presented no evidence of HYG loss in the
absence of tetracycline but also few hygromycin-sensitive wells on induction (0/71 and 6/76,
respectively, equating to a probability of loss in individual cells of�0.08 and 0.1–0.3; p = 0.03,
Fisher’s exact test; Fig 7C). In contrast, induction of T7-driven I-SceI expression resulted in
production of hygromycin-sensitive wells at a rate equivalent to 65–92% of cells losing HYG
across 3 independent clones (Fig 7C and 7D). Although the number of sensitive wells pro-
duced by non-induced lines was also significantly higher with this strong promoter compared
to heterologous rRNA promoter (11/196 and 0/71, respectively; p = 0.04), the estimated loss
for even the highest clone is equivalent to a loss in ~3% of cells per generation (17% over 48 h),
which is sufficiently low for short-term growth without selection.
Inducible double-strand break creation greatly increases transfection
efficiency
To test if double-strand break induction increases transfection efficiency in T. congolense, we
took TcoSM cells transfected with pTcoScetiT7 or pTcoSceTbrRNA, induced I-SceI expression
for 16 h and then introduced a T. congolense RNAi plasmid that targets the Sce-modified locus
(p3T7-TcoV containing a fragment of TUBA; Fig 8A). I-SceI induction time was chosen as
being the approximate peak in specific ssDNA production seen in T. brucei [15] and also for
simple convenience in experimental set-up. It is possible that other lengths of induction would
further change efficiency, but this was not investigated here.
Induction of I-SceI controlled by heterologous rRNA promoter had no impact on transfec-
tion efficiency, which was indistinguishable from transfection of construct into TcoSM cells
(~250 independent clones per transfection; Fig 8B). Induction of T7-driven expression, how-
ever, increased efficiencies to>10,000 clones per transfection (~50-fold above efficiency with-
out cutting). For 2 of 3 independent clones there was evidence of considerable cutting even
without tetracycline (Fig 8B). Given the very low background transcription for tetracycline-
inducible transgenes at this minichromosomal locus, this seems anomalous–particularly as
there was no corresponding loss of HYG in these clones during normal growth (Fig 7D). Our
current hypothesis is that this reflects stochastic displacement of TetR in a proportion of cells
as a result of electroporation stress. This would explain the high variability in the effect
(100-fold between experiments and clones; Fig 8B). Fortunately, it is of no practical disadvan-
tage, as induced efficiencies are consistent and high across clones. Significantly, all clones were
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Fig 8. Increased efficiency of integration at induced double-strand break locus. A) Schematic representation of integration
events and resultant unique amplicon sizes. The targetted locus, TcIL3000.A.H_000093600, is first modified by integration of
pTcoScetiT7 or pTcoSceTbrDNA and may be subsequently replaced by p3T7-TcoV-TUBA, which has the same targeting
sequences. B) Efficiency of stable transfection following induction of double-strand break in 3 independent clones carrying
self-excising locus at minichromosome VSG. Independent replicates of transfection are shown for each clone. Bars: 90%
confidence intervals for estimates in individual transfections. Clone 1 was selected as the progenitor of the TcoTTS cell line.
Freeze/thaw indicates samples that have been stored in liquid nitrogen and defrosted prior to transfection. C) Multiplex PCR
showing modification of minichromosome VSG loci following introduction of a construct targeting the VSG
(p3T7-TcoV-TUBA) after 0 h (-Tet) or 16 h (+Tet) induction of double-strand break at the target locus in TcoTTS cells.
Distinguishable amplicons are produced from unmodified loci (wt), and loci modified by either pTcoScetiT7/pTcoSceTbrDNA
(SceI) or p3T7-TcoV-TUBA (δtuba). D) Production of phenotypic changes due to knockdown of α-tubulin (δtuba) in 2
independent clones produced from TcoTTS cells either without (-) or with (+) induction of double-strand break during
transfection.
https://doi.org/10.1371/journal.ppat.1009224.g008
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also stable to freeze-thawing of cultures (Fig 8B) and could be maintained in culture for at least
3 weeks without loss of high-efficiency.
We selected the clone with greatest fold-change in transfection efficiency as the basis for a
stable library-recipient cell line. This cell line, based on IL3000 TcoSM cells, is named TcoTTS
for the presence of T7RNAP, TetR and inducible I-SceI. TcoTTS cells are compatible with
both our RNAi and over-expression constructs targeting VSG TcIL3000.A.H_000093600, and
are suitable for generation of high-complexity libraries. Optimization of transfection parame-
ters in TcoTTS cells following frozen storage showed that this line can routinely and consis-
tently produce >40,000 independent clones per transfection (using 20 μg input DNA and
5x107 induced cells; Fig 9).
Although the targeted VSG (TcIL3000.A.H_000093600) is present in the long-read IL3000
assemblies as a single copy [5], analysis of integration events shows at least 3 copies in IL3000
cells, since TcoTTS cells contain both modified and unmodified TcIL3000.A.H_000093600
loci and introduction of p3T7-TcoV without induction of I-SceI can either replace pTcoScetiT7
(e.g. clone 1 in Fig 8C) or modify a VSG copy (e.g. clone 3 in Fig 8C) and still leave�1 unmod-
ified copy. Copies of TcIL3000.A.H_000093600 likely represent multiple copies of the mini-
chromosome itself that could not be distinguished during assembly. As expected, induction of
I-SceI pushes all integration events to the single modified locus (Fig 8C), meaning that all inte-
gration events in induced TcoTTS are modified at precisely the same genomic location.
Importantly, phenotypes associated with δtuba could be induced equally in cell lines derived
by I-SceI induction as those derived without induction (Figs 6B and 8D), showing that the pro-
cess does not interfere with generating RNAi against essential genes.
Genetic modified IL3000 cells for in vivo disease models
In order to use directly modified bloodstream-form T. congolense in animal models of disease,
it is necessary that cells following selection still establish infections with reasonable dynamics.
It would also be beneficial to generate forms of IL3000 that can be followed through an infec-
tion by in vivo imaging. To this end, we designed and built constructs to stably express firefly
luciferase using an endogenous rRNA promoter (Fig 10A), in a manner analogous to those
Fig 9. Optimization of transfection efficiency in TcoTTS cells following induction of double-strand break. A single
purified preparation of p3T7-TcoV-TUBA was used for all transfections. Bars: 90% confidence intervals for estimates in
individual transfections.
https://doi.org/10.1371/journal.ppat.1009224.g009
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Fig 10. Transgenic T. congolense bloodstream lines for visualisation of in vivo infection. A) Schematic representation of construct architectures and integration.
Constructs differ only in T. congolense intergenic region between CDSs in transgenic bicistron. B) Luminescence in wild-type (wt) or TcoSM cells stably transfected with
pTcoLUC1 or pTcoLUC2. Technical duplicates from 3 independent clones of each line are shown along with mean and SEM across clones. C) Linearity of luminescence
in the highest-expressing wild-type (wt) or TcoSM LUC1/2 clones. D) Infection dynamics of T. congolense LUC2 cells in a mouse model of AAT monitored by
bioluminescence and parasitaemia in peripheral blood (5 animals for each inoculum). Inoculum refers to total dose of parasites used to infect animal at time 0. E) In vivo
imaging of infection density in mice inoculated with T. congolense LUC2 cells. Numbers below images of individual mice are estimates of the peripheral parasitaemia (cell
ml-1) made by haemocytometry. Data from 2 representative animals for each inoculum are shown.
https://doi.org/10.1371/journal.ppat.1009224.g010
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used in T. brucei [38] and T. vivax [39]. Integration is duplicative, such that transcription of
the downstream RRNA polycistron is not disrupted and the modifications carry no bacterial
DNA to the integration site. Two alternative endogenous intergenic regions from highly
expressed T. congolense genes (between the genes encoding L5 and L15 ribosomal proteins,
and TUBA-TUBB) were placed at the 3’ end of the luciferase CDS. Integration of either con-
struct in IL3000 wild-type or TcoSM cells produced detectable luciferase at levels >1000-fold
above background (Fig 10B), but levels associated with the tubulin intergenic (LUC2) were sig-
nificantly higher (p< 0.001; Student’s t-test). Luminescence in vitro is linear across >5-orders
of magnitude and as few as 10 cells in total are detectable above background (Fig 10C).
To create a model of acute trypanosomiasis, 106 modified LUC2 cells were injected into
BALB/c mice via the intraperitoneal route. First parasitaemic peak was seen at day 4 post-
infection, demonstrating that modified cells are still infectious directly from culture. Cells
from the second parasitaemic wave were further passaged twice in BALB/c mice, each to the
first parasitaemic peak. Luciferase expression was maintained across this in vivo growth in the
absence of selection and infections with this line result in a predictable dose-dependent time to
first peak parasitaemia across at least 2-orders of magnitude (Fig 10D). Infection dynamics are
also very similar in male and female mice and in an albino strain derived from C57BL/6 (S5
Fig). Monitoring parasites by in vivo bioluminescence imaging shows linear doubling of para-
site numbers during exponential growth proportional to the initial dose and with an estimated
in vivo doubling time of 8.4 h. However, counts of parasites in peripheral blood appear to sub-
stantially underestimate total T. congolense abundance at low parasitaemia (Fig 10D)–probably
due to the vascular adherence of parasites that is a feature of T. congolense infections [40]. Dis-
tribution of T. congolense in this acute model extends widely through the animal (Fig 10E) and
there is no strong evidence for tissue-specific accumulation as is seen at later stages of infection
with T. brucei [38] or T. vivax [41].
Discussion
Transfection of bloodstream-form IL3000 cells
Here we have described, for the first time routine, direct genetic modification of bloodstream-
form T. congolense IL3000. Transfection efficiencies when targeting endogenous loci are good
(100–4000 independent clones per transfection)–at least as high as for Lister 427 bloodstream-
form cells, which are the most commonly modified T. brucei strain–and do not require heter-
ologous DNA modifiers, such as recombinases, restriction endonucleases or Cas9. While this
is a great benefit for T. congolense research, it does raise the question as to why previous
attempts at stable transfection proved so challenging.
The IL3000 line used herein is a descendant of the original in vitro bloodstream-form line
[14] and is still infective in animals. Our transfection procedure is covered in detail in Materi-
als and Methods, but is also only modestly different from standard short-pulse electroporation
(‘nucleofection’) procedures used previously–most of which gave no stable transfectants.
Although not systematically addressed, our experience suggests that bloodstream-form T. con-
golense cells are much more sensitive to bacterial endotoxin than T. brucei and high-purity
DNA appears to be an absolute requirement for high efficiency stable transfection. We only
perform transfection with DNA purified by anion exchange and transfection buffer made
from high-purity stocks.
Notwithstanding influence from the above, the major determinant of previous difficulties
in genetic modification of T. congolense is likely to be simply that the constructs were not
designed for this organism, but were heterologous application of T. brucei constructs. Many
genomic elements definitely cannot be transferred in this manner: the T. brucei procyclin
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promoter is not functional in T. congolense [27], and our data suggest that the T. brucei rRNA
promoter has very limited activity. Moreover, while it is clear that at least some T. brucei inter-
genic regions are processed sufficiently in T. congolense to produce detectable levels of protein
[14,17,28], the efficiency of processing compared to native sequences is unknown and likely to
be much lower in many cases. More significantly, the majority of reported transfection
attempts have also used heterologous T. brucei sequence for targeting integration [13,14,17]. It
is unknown how transfection efficiency scales with identity of targeting sequence in T. congo-
lense, but in T. brucei comparable levels of mismatch (10% for TUBB) would cause a 50-fold
decrease in efficiency [42]. This may not explain all the improvement in efficiency we have
achieved (perhaps as much as 1000-fold), but likely provides a substantial contribution. Impor-
tantly, this implies that, although the work here is focused on bloodstream-form cells, all the
tools developed will also greatly facilitate work using other replicative stages. None of our T.
congolense constructs contain stage-specific elements and we have shown that procyclic-form
cells can be modified with similar ease to bloodstream forms (Fig 1)–with approximately
500-fold greater efficiency than previous studies (>50 and ~0.1 independent clones per million
cells, respectively; [17]).
RNAi effectiveness in T. congolense IL3000
Tetracycline-regulated T7RNAP-driven transcription from minichromosomal loci in TcoSM
cells is at least as strong with respect to pol II transcription as in T. brucei SMB and 90-13 lines
[21], but T7-based RNAi in T. congolense had consistently lower effect size compared to typical
T. brucei knockdowns. To our knowledge, there are no published systematic tests of the effect
of dsRNA length on knock-down effectiveness in T. brucei, although fragments as small as 50–
60 bp have been reported to reduce endogenous mRNA levels when expressed in cells [36,43].
In the absence of strong evidence for length effects, most knockdowns using head-to-head pro-
moter arrangements in T. brucei employ fragments in the range 250–800 bp. In our T. congo-
lense system, gene fragments in the range ~500–800 bp reduced mRNA and protein levels to
~30–50% of parental levels with no evidence for length effects. It is possible that much longer
dsRNA could increase RNAi effectiveness in T. congolense, but current data suggest this is
unlikely. Moreover, similar levels of knockdown were seen previously when expressing RNA
hairpins from constitutively active loci [13] and our attempts to improve RNAi effect size
using inducible single-promoter hairpins gave no greater phenotype penetrance than head-to-
head constructs. These data imply that T. congolense and/or the IL3000 strain have an intrinsi-
cally lower RNAi effect size than commonly tested T. brucei strains. This does not appear to be
due to differences in expression of the core RNAi machinery, as levels of mRNA encoding the
trypanosome homologues of Argonaute [44,45], Dicer [46,47] and the RNA Interference Fac-
tor 4 (RIF4) are slightly higher in bloodstream-form T. congolense compared to T. brucei (Fig
11A). The encoded proteins are also well conserved within African trypanosomes and no
more divergent in T. congolense than would be expected from lineage history (Fig 11B).
Importantly, although RNAi effectiveness–both in terms of proportion of cells exhibiting a
defect and the defect severity–is lower than in T. brucei, knockdown is sufficient to produce
gross morphological defects in ~50% of cells when targeting two essential genes. This effect on
only part of a clonal population does not appear to be due to a high proportion of refractory
cells. It appears instead to be a threshold effect, and progeny of cells that had no detectable
morphological change can go on to develop defects. As a result, the corresponding halving of
the population growth rate after 24 h RNAi induction is persistent, at least over a few days, and
a large difference in total cell numbers can thus accumulate (~20-fold difference by 5 days
post-induction). This means that, even in the absence of dramatic cell death, such RNAi-
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induced changes are readily amenable to identification by high-throughput methods relying
on differential cell growth such as RIT-Seq (for example, the fold-change in TUBA fragments
by day 6 of RIT-Seq in T. brucei is also ~20-fold; [16]). This is particularly relevant given that
we have also developed here a system for production of high-complexity libraries in T. congo-
lense analogous to Sce� cells used in T. brucei [15].
A toolkit for functional genetics in Trypanosoma congolense
Work in T. brucei (and then only in a limited set of strains) dominates functional genetics in
African trypanosomes. This is in spite of T. congolense and T. vivax being the more important
parasites for AAT and it being known that the species differ in significant aspects of their biol-
ogy. The dominance of T. brucei work is due in large part to the wealth of tools for functional
genetics built up across more than 3 decades of work. Here we have attempted to substantially
accelerate work in T. congolense by developing a basic set of tools and methods that open the
organism up to functional genetics–designing each tool from first principles to suit the T. con-
golense genome.
With homologous targeting sequences, we have shown that modification of endogenous
loci for tagging or gene knockout is routine in T. congolense, even for bloodstream stages. To
date, we have only used 3 selective drugs (hygromycin, G418 and puromycin), but bleomycin
has been used elsewhere [14,28] and additional selective drugs used in T. brucei are highly
Fig 11. Expression and conservation of components of the RNAi machinery in T. brucei and T. congolense. A)
Total mRNA levels (fragments per million; FPM) for AGO1, DCL1, DCL2 and RIF4 homologues in bloodstream-form
cells. For comparison, the distribution of FPM for all detected genes is also shown (grey). RNA levels for the 3 near-
identical AGO1 genes in T. congolense (>99% identical at the nucleotide level and indistinguishable across most of their
length in RNA-Seq) have been summed to reflect the total levels of mRNA for the protein. B) Maximum likelihood
phylogenies for homologues of components in Leishmania braziliensis (LbrM), Trypanosoma grayi (DQ4), T. vivax
(TvY486), T. congolense (TcIL3000) and T. brucei. Sequence for both Lister 427 (Tb427) and TREU927/4 (Tb927)
strains are shown for T. brucei. T. congolense gene models suffixed “_full” have been corrected to start at the
unannotated in-frame ATG, which in all cases produces an uninterrupted CDS>99% identical to either
TcIL3000_10_9140 or TcIL3000_10_9150 in the short-read assemblies. Phylogenies were inferred from aligned protein
sequences using FastTree 2.1.9 ([60]; LG substitution matrix, gamma-distributed variation in substitution rate
approximated to 12 discrete categories). Node support is derived from 100 bootstrap replicates.
https://doi.org/10.1371/journal.ppat.1009224.g011
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likely to be usable. Development of a well-regulated system for inducible ectopic (over-)expres-
sion was a key early tool in T. brucei. We have described a T. congolense single marker line
(TcoSM) that expresses codon-optimized TetR and T7RNAP using T. congolense-specific pro-
cessing sequences. Combining this line with the use of minichromosomal loci as stable, silent
targets for inducible transgenes brings levels of expression in the absence of induction from
only ~4-fold below induced as previously achieved [14] to below the level of detection
(>700-fold regulation), creating a system suitable for toxic gene expression or conditional
knockouts. We have also designed a T. congolense-specific RNAi construct, p3T7-TcoV, that
integrates at a silent minichromosomal VSG and validated it against multiple genes. This is by
no means the first application of RNAi in T. congolense, which goes back nearly two decades
[28], but should greatly increase the utility of a technology that has been so important in analysis
of gene function in T. brucei. To date, we have seen no evidence of significant clonal variation
in knockdown at the mRNA, protein or phenotypic levels, suggesting that we can anticipate
good reproducibility of RNAi using p3T7-TcoV. In addition to this, genetically modified
IL3000 bloodstream-form cells are still infectious and the production of a stable, highly-lumi-
nescent line provides a tool for vaccinology or other work requiring in vivo disease models.
Since modified T. congolense minichromosomes have good stability in the absence of selection,
this system also allows regulation of transgene expression or RNAi during an infection.
The tools above enable work analogous to the majority of studies in T. brucei to be per-
formed directly in bloodstream-form T. congolense. Since specific modification of endogenous
loci in bloodstream-form T. congolense is now routine, we have not prioritized testing of
CRISPR/Cas systems in the first instance, but such a system would be a useful future extension
to allow modification of multiple alleles/loci. However, some of the most transformative tech-
nologies in T. brucei in recent years depend on the production of not individual mutants, but
libraries containing many thousand mutants (e.g. RIT-Seq [16,37]). The TcoTTS line
(T7RNAP, TetR and inducible I-SceI) allows high-complexity library production in T. congo-
lense for the first time, robustly giving >40,000 independent clones per transfection with
p3T7-TcoV. Importantly, this is sufficient efficiency for genome-scale applications encompass-
ing several mutants for each gene in the genome. The stability of TcoTTS with respect to stor-
age and at least medium-term growth is an additional convenience in comparison to the
current technology in T. brucei as it removes the need for fresh derivation before each experi-
ment. Moreover, since all copies of the locus appear to behave indistinguishably with respect
to transgene expression/RNAi, this technology can be trivially recreated in other parental lines
without the necessity of screening multiple clones.
The work here is focused on bloodstream-form T. congolense, as the lifecycle stage of highest
experimental interest. However, all the constructs developed are applicable without modifica-
tion in other stages–an application for which T. congolense is well-suited due to the ability to
reproduce its whole lifecycle in vitro [14]. It also provides an example of the application of
genome and transcriptomic sequence information, cost-effective DNA engineering tools, and
information from decades of work in T. brucei for the rapid development of functional genetics
in other important disease-causing trypanosomes. Application of this to other lines or species is
relatively easy, but can only be applied to cells that can be grown as stable in vitro cultures.
Materials and methods
Ethics statement
Animal experiments were performed under UK Home Office regulations (project licences
PD3DA8D1F and P98FFE489) and European directive 2010/63/EU. Research was ethically
approved by the Sanger Institute Animal Welfare and Ethical Review Board.
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Cell culture and transformation
Bloodstream-form T. congolense IL3000 strain, originally isolated at the International Live-
stock Research Institute (Nairobi, Kenya) and derived from infected mouse blood by [14], was
a kind gift of Prof. Mike Barrett (University of Glasgow, UK). Cells were cultured at 34˚C and
5% CO2 in TcBSF1 without red blood cells [14], with the modification that only 15% goat
serum (GIBCO) was used and no serum-plus. Procyclic-form T. congolense IL3000 were a
kind gift of Prof. Wendy Gibson (University of Bristol, UK) and were cultured in unvented
flasks at 28˚C in TcPCF3 [14]. Bloodstream-form T. brucei was grown in HMI-9 medium sup-
plemented with 15% fetal bovine serum at 37˚C and 5% CO2 [48].
2-3x107 cells and 10 μg of cut plasmid were used unless otherwise stated in the text. DNA
was concentrated for transfection by ethanol precipitation and resuspension in 30 μl Tb-BSF
(90 mM sodium phosphate, 5 mM KCl, 0.15 mM CaCl2, 50 mM HEPES, pH 7.3; [49]).
Actively-dividing, healthy cells (at ~2x106 and ~2x107 cells ml-1, for bloodstream- and procyc-
lic-form trypanosomes, respectively) were harvested by centrifugation at 1200 g for 10 min,
washed in a small volume of Tb-BSF, re-pelleted at 1200 g for 2 min, and resuspended in 90 μl
Tb-BSF. Cut DNA in Tb-BSF was added to these suspensions (final volume of 120 μl) and cells
were electroporated in 2 mm cuvettes using an Amaxa Nucleofector 2b device (Lonza) with
program ‘Z-001’. Cells were quickly transferred to flasks containing pre-warmed medium and
allowed to recover for 8 h. After recovery, selection was applied by addition of antibiotics to
final concentrations of 0.5 μg ml-1 puromycin, 0.2 μg ml-1 G418, or 0.5 μg ml-1 of hygromycin
B. For pGad constructs (containing a single GFP and drug polycistron), selection was carried
out in the presence of induction with 1 μg ml-1 tetracycline.
For transfection of TcoTTS cells with induction of I-SceI expression, the same procedure
was followed as above, except that selective pressure for background (hygromycin B) was
removed from cells 48 h prior to electroporation, and 1 μg ml-1 tetracycline added 16 h prior
to electroporation.
To estimate transfection efficiency, samples of cells immediately following recovery after
electroporation were diluted in fresh, selective medium and distributed across 96 well plates.
The proportion of total population plated was selected based on expected transfection effi-
ciency, but for routine transfections 20% and 4% of each transfection was plated on 2 indepen-
dent plates, and 2% and 0.4% for induced TcoTTS cells (providing accurate estimates of
efficiency in ranges 100–6000 and 1000–60000 independent clones, respectively). Numbers of
independent transfectants were derived from the number of positive wells based on the
expected Poisson-distributed filling of wells. Confidence intervals of estimates were derived
from the distribution of quantiles of 106 simulated platings at 0.001 to 10 cells well-1.
Induction of RNAi or ectopic transgene expression was by addition of 1 μg ml-1 tetracycline
to culture medium.
Design and construction of plasmids
Sequences and graphical maps for all new constructs used in this work are available at www.
wicksteadlab.co.uk and www.catarinagadelha.com, and also in S1 Dataset. All primers used for
amplification of T. congolense targeting sequences are provided in S1 Table.
For tagging of proteins by modification of endogenous loci, constructs were derived from
pEnNY0, pEnNmSt0-N [50] and pEnNmSc0-N [51] in the case of N-terminal tagging, or
pSiS-HHsfG [34] for C-terminal tagging. In all cases, 300–800 bp of targeting sequence from
each side of the integration site was amplified from T. congolense IL3000 genomic DNA and
incorporated into the constructs using standard methods (see S1 Table). pGad10-TcoTUB, for
knockout of a TUBB allele in T. congolense, was derived from pGad9 [26] by replacement of 5’-
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and 3’- end of the GFP-HYG polycistron (without the promoter) by TUBA-TUBB and TUBB--
TUBA intergenic regions, respectively (see S1 Dataset).
Since codon usage bias is very similar between T. brucei and T. congolense, CDS encoding
TetR and T7RNAP for pTcoSM were taken from pSmOx ([22]; kindly provided by Steve Kelly,
University of Oxford). All intergenic and targeting regions were amplified from T. congolense
IL3000 genomic DNA, and the construct built by Gibson assembly in a pBluescriptII-SK
(+)-derived backbone (see S1 Dataset).
Constructs for ectopic inducible expression of GFP from minichromosomal loci were
derived from pGad9 [26] by incorporating 300–800 bp targeting sequences from each side of
the integration sites amplified from T. congolense IL3000 genomic DNA. Amplicons of 369 bp
repeat were size-selected for 2 tandem repeats (1 repeat at each end of integration site) by exci-
sion from agarose gel. p2T7-TcoV was derived from p2T7Ti [33], pEnNmSt0-N [50] and
amplicons from T. congolense IL3000 genomic DNA by Gibson assembly (see S1 Dataset).
This was subsequently modified to create p3T7-TcoV and p3T7-TcoVTT by standard means.
To generate a self-excising construct that creates double-strand breaks at minichromosomal
VSG, sequence encoding I-SceI with an N-terminal nuclear localisation signal and C-terminal
HA tag controlled by an inducible T. brucei rRNA promoter was obtained from pLew100::
NLS-ISceI-HA ([52]; kindly provided by Nina Papavasiliou, German Cancer Research Center,
Heidelberg). This was combined by Gibson assembly with sequence elements from pGad9 and
p3T7-TcoV to create pTcoSceTbrRNA, which was subsequently modified by replacement of the
inducible promoter by standard means to create pTcoScetiT7.
For stable expression of luciferase, CDS encoding firefly luciferase was taken from
pLEW100 [21] and neomycin resistance cassette from p3T7-TcoV. These were assembled with
amplicons from T. congolense IL3000 genomic DNA by Gibson assembly in a pBluescriptII-SK
(+)-derived backbone.
All constructs were amplified in XL1 Blue Escherichia coli and purified using an anion-
exchange column of the appropriate size (QIAGEN plasmid kits).
Quantitative analysis of RNA
All RNA preparations were made from 6-10x107 actively growing cells using High Pure RNA
isolation kit (Roche) and integrity of RNA assessed by denaturing agarose gel electrophoresis.
For RNA-Seq, sample preparation and sequencing was performed by University of Notting-
ham Deep Seq facility. RNA concentrations were measured using a Qubit Fluorometer and
Qubit RNA BR Assay Kit (ThermoFisher Scientific) and integrity assessed using a TapeStation
4200 and RNA ScreenTape Assay Kit (Agilent). mRNA was purified from 1 μg of total RNA
using the NEBNext Poly(A) mRNA Magnetic Isolation Module (New England BioLabs).
Indexed sequencing libraries were then prepared using the NEBNext Ultra Directional RNA
Library Preparation Kit for Illumina (New England BioLabs) and NEBNext Multiplex Oligos
for Illumina, Index Primers Set 2 and Set 3 (New England BioLabs). Libraries were quantified
using a Qubit Fluorometer and Qubit dsDNA HS Kit (ThermoFisher Scientific). Fragment-
length distributions were analysed using a TapeStation 4200 and High Sensitivity D1000
ScreenTape Assay (Agilent). Libraries were pooled in equimolar amounts and final library
quantification performed using the KAPA Library Quantification Kit for Illumina (Roche).
The pool was sequenced using a NextSeq 500 System (Illumina) and mid-output 150 cycle kit
v2.5 (Illumina), providing >12 million pairs of 75-bp paired-end reads passing filter per sam-
ple. http://www.ebi.ac.uk/ena
Reads were trimmed for quality and adapter using Trim Galore v0.4.4 (www.
bioinformatics.babraham.ac.uk; -q 28—illumina—stringency 3—length 50) and aligned the
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TriTrypDB T. congolense IL3000_2019 or T. brucei Lister 427_2018 assemblies (v46; based on
the work of [5,53]) using bowtie2 v2.3.4 ([54];—no-mixed—no-discordant -I 50 -X 500). Total
transcript abundance was assessed using HTSeq v0.5.4 [55]. Read depth analysis was per-
formed using bedtools v2.25.0 [56].
For quantitative RT-PCR of transcripts in δchc cells, total RNA was reverse transcribed
using avian myeloblastosis virus reverse transcriptase (New England BioLabs) primed by
T15N. cDNA (or no-RT control) generated from 20 ng total RNA was used as template in
each PCR reaction replicate. qPCR was performed on an Mx3000 system (Agilent) with a stan-
dard Taq polymerase mix supplemented with 0.5x EvaGreen dsDNA dye (Biotium). Target
mRNA levels were normalised using levels of PFR1 (TcIL3000.A.H_000346600) transcript. For
quantitative RT-PCR in other RNAi cell lines, total RNA was reverse transcribed using a High
Capacity cDNA RT kit (Applied Biosystems). qPCR reactions were carried out with SensiFAST
SYBR Hi-ROX mix (Bioline), in a Rotor-Gene 3000 system (Corbett Research). Target mRNA
levels were normalised using levels of TERT (TcIL3000.A.H_000960200, for other RNAi) tran-
script. Primers for TERT were as in [57], other primers used in quantitative PCR are provided
in S2 Table. Samples were biological triplicates (for individual clones) or duplicates of 2 inde-
pendent clones (δchc).
Microscopy
For analysis of localisation of tagged proteins or soluble fluorescent protein by native fluores-
cence, cells were harvested from mid-log phase cultures, washed twice in phosphate-buffered
saline (PBS; 137 mM NaCl, 3 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) and allowed to
settle for 5 min onto glass slides at ~2x107 cell ml-1 density. Cells were fixed for 5 min in 2%
(w/v) formaldehyde, permeabilised in -20˚C methanol for 10 min, re-hydrated in PBS and
incubated with 15 ng ml-1 40,6-diamidino-2-phenylindole for 5 min, before mounting in 1%
(w/v) 1,4-diazabicyclo[2.2.2]octane, 90% (v/v) glycerol, 50 mM sodium phosphate, pH 8.0.
Counter-staining of cells expressing ESP14-sfGFP was by incubation with 25 μg ml-1 tomato
lectin conjugated to AlexaFluor 594 (Invitrogen) for 20 min. Images were captured on an
Olympus BX51 microscope equipped with a 100x UPlanApo objective (1.35 NA; Olympus)
and Retiga R1 CCD camera (Qimaging) without binning. All images of fluorescent proteins
were captured at equal exposure settings without prior illumination. Images for level compari-
son were also processed in parallel with the same alterations to minimum and maximum dis-
play levels, except where stated. Image acquisition was controlled by μManager open source
software [58]. Processing and analysis were performed in ImageJ [59].
Immunoblotting
To test either tagged protein ablation by RNAi or ectopic gene expression, lysates from 2x107
cells were separated by reducing SDS-polyacrylamide gel electrophoresis and electro-trans-
ferred onto nitrocellulose membrane (GE healthcare) in 25 mM Tris, 192 mM glycine, 0.02%
SDS, 10% methanol. Membranes were blocked with 5% (w/v) skimmed milk in TBS-T (20
mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% (v/v) Tween-20) and protein detected by either
800 ng ml-1 mixture of two anti-GFP monoclonal antibodies (7.1 and 13.1; Roche), or 500 ng
ml-1 anti-tetracycline repressor protein monoclonal antibody (9G9; Clontech), followed by 80
ng ml-1 goat anti-mouse immunoglobulins conjugated to horseradish peroxidase (Sigma) in
TBS-T containing 1% (w/v) skimmed milk. Antibodies were detected using Western Lightning
enhanced chemiluminescence reagent (GE healthcare) captured on a Fusion FX Spectra (Vil-
ber Lourmat).
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Flow cytometry
For quantitative analysis of fluorescence by flow cytometry, ~3x106 cells were harvested by
centrifugation at 1200 g, 5 min and resuspended in 120 μl PBS containing 1% (w/v) formalde-
hyde, 0.2% (w/v) glutaraldehyde and 10 μg ml-1 propidium iodide. This suspension was incu-
bated at room temperature for 10 minutes, after which time the suspension was diluted 5-fold
with PBS and analysed on a FC500 flow cytometer (Beckman Coulter), collecting a>20,000
gated events for each sample. Events were gated on the basis of forward- and side-scatter to
remove clumps of cells and debris, and only cells with intact plasma membrane (negative for
propidium) were included for analysis.
Testing of double-strand break induction
To test for loss of HYG due to induction of I-SceI endonuclease expression, cells were removed
from hygromycin selection and cultured with or without 1 μg ml-1 tetracycline for 48h. These
cultures were then diluted in fresh culture medium without antibiotic, and distributed across
96 well plates at an estimated 1.5 cells well-1. After growth for 7 days, plates were replicated by
5-fold dilution into plates containing fresh medium with or without 2 μg ml-1 hygromycin B
and cultured for a further 1.5 days. The number of wells that had become hygromycin-sensi-
tive was used to derive the proportion of HYG-negative cells based on Poisson-distributed fill-
ing of wells (λ estimated from populated wells on initial plating) and Binomially-distributed
loss of HYG. Confidence intervals of estimates were derived from the distribution of quantiles
from 106 simulated platings with resampling λ (Normally-distributed around each estimate)
and a range of probability of loss from 0–1.
Genotypic analysis of modified cell lines
For testing of genotypes by PCR, ~105 cells from clonal lines or populations were harvested,
washed in PBS and subjected to hot alkaline lysis in 50 mM NaOH, 2 mM EDTA for 10 min at
95˚C, followed by neutralisation by addition of Tris-HCl pH 6.8 to a final concentration of 75
mM. Small samples of these preparations were used as templates in multiplex PCR using prim-
ers for specific bait regions to screen transformants.
Infections with transgenic T. congolense and bioluminescence
measurements
In vitro luciferase activity was detected using the Luciferase Reporter Gene Assay, high sensi-
tivity (Roche) and luminescence detected using a Glomax 96 Microplate Luminometer (Pro-
mega). For infections, female BALB/c strain animals were used except where indicated.
Bloodstream-form T. congolense LUC2 cells were obtained from an infected donor mouse at
the peak of parasitaemia, diluted in PBS supplemented with 20 mM glucose and used to inocu-
late recipient mice by intravenous injection at total doses of 100, 1000, or 10,000 parasites. D-
luciferin was administered to animals at a dose of 200 mg kg-1, by intraperitoneal injection 10
minutes before imaging. The mice were allowed 3 minutes of movement before being anaes-
thetized and placed in the imaging chamber where anaesthesia was maintained during acquisi-
tion. In vivo bioluminescence was captured on an IVIS Spectrum Imaging System (Perkin
Elmer) and quantified using Living Image software (Xenogen).
Supporting information
S1 Fig. Localisation of proteins by modification of endogenous loci in bloodstream-form
T. congolense. Representative fields of view are shown for cells expressing T. congolense ESP10
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C-terminally tagged with superfolder GFP (ESP10-sfG), or Nopp140 N-terminally tagged with
mStrawberry (mSt-Nopp140). Native fluorescence from tagged proteins is shown, alongside
counter-staining with 40,6-diamidino-2-phenylindole (DAPI; cyan). ESP10-sfG cells have been
additionally stained with AlexaFluor 594-conjugated tomato lectin (TL), to highlight the flagel-
lar pocket and endosomal machinery.
(TIF)
S2 Fig. Levels of transgenic TetR produced in modified cells. Figure shows full view of
immunoblot membrane excerpted in Fig 2D containing transferred whole cell lysates. Ponceau
S staining is shown as a control for loading, plus two exposures of the membrane immuno-
blotted with an anti-TetR monoclonal antibody. ‘wt’ indicates unmodified parental cells.
(TIF)
S3 Fig. Distribution of cellular fluorescence in cell lines expressing transgenic GFP from
endogenous loci or ectopic inducible loci, and in the presence of RNAi against GFP. A)
Violin plots of green fluorescence of cells expressing GFP from the tubulin locus (Δtubb::GFP)
or from inducible minichromosomal loci in 0 (non-induced) or 1 μg ml-1 (induced) tetracy-
cline (see Figs 3A and 4A). B) Violin plots of green fluorescence of cells expressing GFP from
the tubulin locus (Δtubb::GFP) in which RNA-interference against GFP had been induced (see
Fig 5A and 5B). Median and range of 5% and 95% quantiles are shown by dot and bars, respec-
tively.
(TIF)
S4 Fig. Stability of phenotypes associated with knockdown of clathrin heavy chain to con-
tinuous passage or freeze-thaw of cell lines. Proportions of cells with clear morphological
defect (see Fig 6) are shown for cells with no RNAi construct (parental) and two independent
clones of δchc cells following 0 or 48 h induction with tetracycline. Clones had previously been
grown in culture for 1 week or 8 weeks following transfection and selection, or frozen after 1
week in culture, stored under liquid nitrogen and then brought back into growth (freeze-
thaw). Bonferroni adjusted p-values from proportions test are shown above columns (n/s: not
significant; �: p<0.05; ���: p<0.001).
(TIF)
S5 Fig. Infection dynamics of T. congolense LUC2 cells in different albino mouse strains.
Male or female BALB/c and male B6 Albino (C57BL/6N-TyrcWTSI) were infected with 1000 T.
congolense LUC2 cells at time 0 and dynamics monitored by whole-animal bioluminescence.
Data from 15 independent infections using male BALB/c and B6 Albino animals, and 4 infec-
tions with female BALB/c animals are shown.
(TIF)
S1 Dataset. Sequences and graphical maps for all new constructs used in this work. Anno-
tated sequences are provided in GenBank format and were used to generate graphical maps.
(ZIP)
S1 Table. All primers used for amplification of T. congolense targeting sequences.
(XLSX)
S2 Table. Primers used in quantitative RT-PCR.
(XLSX)
S1 Supporting Information. Data supporting figures in main document and supplement.
(XLSX)
PLOS PATHOGENS Tractable functional genetics in bloodstream-form Trypanosoma congolense
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009224 January 22, 2021 25 / 29
Acknowledgments
We are grateful to Mike Barrett (University of Glasgow) and Wendy Gibson (University of
Bristol) for providing bloodstream-form and procyclic IL3000 cells, respectively. pSmOx and
pLew100::NLS-ISceI-HA were gifts of Steve Kelly (University of Oxford) and Nina Papavasi-
liou (German Cancer Research Center, Heidelberg), respectively. pLew100::NLS-ISceI-HA
was obtained via AddGene (#21299). We thank Tom Miller (University of Nottingham) for
assistance with immunoblotting. RNA sequencing and library preparation were performed by
Nadine Holmes in the Deep Seq facility, University of Nottingham.
Author Contributions
Conceptualization: Catarina Gadelha, Bill Wickstead.
Data curation: Catarina Gadelha, Bill Wickstead.
Formal analysis: Georgina Awuah-Mensah, Jennifer McDonald, Pieter C. Steketee, Delphine
Autheman, Sarah Whipple, Simon D’Archivio, Gavin J. Wright, Liam J. Morrison, Catarina
Gadelha, Bill Wickstead.
Funding acquisition: Gavin J. Wright, Liam J. Morrison, Catarina Gadelha, Bill Wickstead.
Investigation: Georgina Awuah-Mensah, Jennifer McDonald, Pieter C. Steketee, Delphine
Autheman, Sarah Whipple.
Project administration: Catarina Gadelha, Bill Wickstead.
Resources: Simon D’Archivio, Cordelia Brandt, Simon Clare, Katherine Harcourt.
Supervision: Gavin J. Wright, Liam J. Morrison, Catarina Gadelha, Bill Wickstead.
Validation: Georgina Awuah-Mensah, Jennifer McDonald, Pieter C. Steketee, Sarah Whipple.
Visualization: Georgina Awuah-Mensah, Pieter C. Steketee, Delphine Autheman, Catarina
Gadelha, Bill Wickstead.
Writing – original draft: Catarina Gadelha, Bill Wickstead.
Writing – review & editing: Georgina Awuah-Mensah, Jennifer McDonald, Pieter C. Steketee,
Delphine Autheman, Sarah Whipple, Simon D’Archivio, Cordelia Brandt, Simon Clare,
Katherine Harcourt, Gavin J. Wright, Liam J. Morrison, Catarina Gadelha, Bill Wickstead.
References
1. United Nations. http://www.fao.org/paat/the-programme/the-disease/en/. 2014.
2. Sheferaw D, Abebe R, Fekadu A, Kassaye S, Amenu K, Data D, et al. Prevalence of bovine trypanoso-
mosis and vector density in a dry season in Gamo-Gofa and Dawuro Zones, Southern Ethiopia. Vet
Parasitol Reg Stud Reports. 2019; 18:100343. https://doi.org/10.1016/j.vprsr.2019.100343 PMID:
31796171
3. Tchamdja E, Kulo AE, Vitouley HS, Batawui K, Bankolé AA, Adomefa K, et al. Cattle breeding, trypano-
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